Big Data and the Opioid Crisis: Balancing Patient Privacy with Public Health
Authors:
- 1 January 2018
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of Law, Medicine & Ethics
- Vol. 46 (2) , 440-453
Abstract
Parts I through III of this paper will examine several, increasingly comprehensive forms of aggregation, ranging from insurance reimbursement “lock-in” programs to PDMPs to completely unified electronic medical records (EMRs). Each part will advocate for the adoption of these aggregation systems and provide suggestions for effective implementation in the fight against opioid misuse. All PDMPs are not made equal, however, and Part II will, therefore, focus on several elements — mandating prescriber usage, streamlining the user interface, ensuring timely data uploads, creating a national data repository, mitigating privacy concerns, and training doctors on how to respond to perceived doctor-shopping — that can make these systems more effective. In each part, we will also discuss the privacy concerns of aggregating data, ranging from minimal to significant, and highlight the unique role of stigma in motivating these concerns. In Part IV, we will conclude by suggesting remedial steps to offset this loss of privacy and to combat the stigma around SUDs and mental health disorders in general.Keywords
This publication has 17 references indexed in Scilit:
- State Legal Restrictions and Prescription-Opioid Use among Disabled AdultsNew England Journal of Medicine, 2016
- Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death RatesHealth Affairs, 2016
- Evidence for effective interventions to reduce mental health-related stigma and discrimination in the medium and long term: Systematic reviewThe British Journal of Psychiatry, 2015
- Effect of Florida’s Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and UseJAMA Internal Medicine, 2015
- Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring ProgramDrug and Alcohol Dependence, 2015
- How Clinicians Use Prescription Drug Monitoring Programs: A Qualitative InquiryPain Medicine, 2014
- Reductions in prescription opioid diversion following recent legislative interventions in FloridaPharmacoepidemiology and Drug Safety, 2013
- Associations between pain clinic density and distributions of opioid pain relievers, drug-related deaths, hospitalizations, emergency department visits, and neonatal abstinence syndrome in FloridaDrug and Alcohol Dependence, 2013
- Estimating the Prevalence of Opioid Diversion by “Doctor Shoppers” in the United StatesPLOS ONE, 2013
- A Statewide Prescription Monitoring Program Affects Emergency Department Prescribing BehaviorsAnnals of Emergency Medicine, 2010